Slough, United Kingdom

Stevan Graham Shaw

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Stevan Graham Shaw - Innovator in Therapeutic Antibodies

Introduction

Stevan Graham Shaw is an accomplished inventor based in Slough, GB, with a remarkable portfolio of eight patents. His work primarily focuses on the development of innovative therapeutic antibodies, aimed at treating various diseases. His contributions to the field have garnered significant attention, reflecting his dedication to advancing medical science.

Latest Patents

Among his latest patents, one of the notable inventions is related to "Anti-FcRn antibodies." This disclosure includes antibodies that specifically target FcRn, along with formulations for these antibodies and their therapeutic applications. Additionally, he has developed processes for expressing, formulating, and encoding these antibodies, which can be crucial in clinical settings. Another significant patent is for "Methods of treatment using anti-IL-17A/F antibodies," which addresses the therapeutic use of antibodies with specificity for both IL-17A and IL-17F. This invention holds promise for treating dermatological and rheumatological diseases such as psoriasis, psoriatic arthritis, and axial spondyloarthritis.

Career Highlights

Stevan has had an impressive career, contributing to leading companies in the pharmaceutical industry. He has worked at UCB Pharma and UCB Biopharma SRL, where he focused on developing therapies that leverage the potential of antibody technologies. His expertise in biopharmaceuticals has played a vital role in advancing treatments for various conditions.

Collaborations

Throughout his career, Stevan has collaborated with notable professionals, including Alastair David Griffiths Lawson and Andrew Malcolm Nesbitt. These partnerships have helped foster an environment of innovation and research, leading to significant advancements in therapeutic products.

Conclusion

Stevan Graham Shaw's contributions to the field of therapeutic antibodies showcase his commitment to innovation and improving healthcare outcomes. With his extensive patent portfolio and collaborations with esteemed colleagues, he continues to make a lasting impact in the realm of medical therapies. His work not only enhances our understanding of diseases but also opens new pathways for treatment and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…